XEN Gelatin: Evolution of a new Glaucoma Surgery
Australian ophthalmologists and researchers have made significant inroads into managing glaucoma. Professor William Morgan from Lions Eye Institute, University of Western Australia, was integral to the development of a microfistula tube, now known as the 'XEN gelatin' implant.
New research: exercise may reduce risk of glaucoma
Moderate intensity exercise appears to be safe and likely beneficial for most people, including glaucoma patients. Patients with glaucoma, especially normal tension, or advanced disease, may be at risk of further optic nerve injury with the pressure fluctuations of strenuous exercise, and should have a personalised exercise plan with their ophthalmologist and health care team.
Genetics promise personalised treatment to prevent glaucoma blindness
Glaucoma Australia welcomes the announcement that the Australian Government will be investing $9.46 million into genetics research aimed at preventing glaucoma blindness.
The clue is in your eyes: New research identifies conclusive link between Alzheimer’s and glaucoma
A new international study led by Australian researchers has provided a conclusive link between glaucoma and Alzheimer’s, with implications for earlier diagnosis and improved treatments for patients in the future.
Ganglion cell deaths can now be imaged in real time in glaucoma patients
A new imaging technique called Detection of Apoptosing Retinal Cells (DARC), could be the future tool for early detection of glaucoma.
Zinc chelation protects optic nerve and ganglion cells after injury
Removing excess zinc after optic nerve injury could protect ganglion cells and optic nerve in glaucoma.
GDF15: a new biomarker yields early detection of neurodegeneration in glaucoma
Is it possible to detect glaucoma even earlier? The answer is yes - by identifying molecular markers that predict or measure neurodegeneration in glaucoma.
Disappointment? Is cannabis effective in the treatment of glaucoma?
Disappointment Is cannabis effective in the treatment of glaucoma
The short-term benefit of lowered IOP lasting hours means patients need to consume cannabis many times a day in order to achieve a constant decrease in IOP